一名患有基础血液系统恶性肿瘤的危重症COVID-19患者尸检证实的由毛霉菌引起的肺毛霉病
Autopsy Proven Pulmonary Mucormycosis Due to in a Critically Ill COVID-19 Patient with Underlying Hematological Malignancy.
作者信息
Zurl Christoph, Hoenigl Martin, Schulz Eduard, Hatzl Stefan, Gorkiewicz Gregor, Krause Robert, Eller Philipp, Prattes Juergen
机构信息
Section of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria.
Division of General Pediatrics, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, 8036 Graz, Austria.
出版信息
J Fungi (Basel). 2021 Jan 27;7(2):88. doi: 10.3390/jof7020088.
Viral infections can cause acute respiratory distress syndrome (ARDS), consequently leading to susceptibility for secondary pulmonary infections. Over the past few weeks, a number of studies have reported on secondary pulmonary aspergillosis complicating severe COVID-19. We report the case of a 53-year old male patient with secondary acute myeloid leukemia (AML) who suffered from COVID-19 ARDS and was diagnosed postmortem with mucormycosis.
病毒感染可导致急性呼吸窘迫综合征（ARDS），进而增加继发肺部感染的易感性。在过去几周里，多项研究报告了严重新型冠状病毒肺炎（COVID-19）并发继发性肺曲霉病的情况。我们报告一例53岁男性继发性急性髓系白血病（AML）患者，该患者患有COVID-19 ARDS，尸检诊断为毛霉病。
Zotero 插件